Version of Record online: 24 SEP 2010
© 2010 Wiley Periodicals, Inc.
Volume 23, Issue 5, pages 514–522, September/October 2010
How to Cite
Stika, C. S. (2010), Atrophic vaginitis. Dermatologic Therapy, 23: 514–522. doi: 10.1111/j.1529-8019.2010.01354.x
- Issue online: 24 SEP 2010
- Version of Record online: 24 SEP 2010
- atrophic vagina;
- atrophic vaginitis;
- estrogen deficiency;
- estrogen replacement therapy;
- vulvar diseases
With the loss of estrogen that occurs with menopause, physiologic and structural changes occur within the vulvovaginal mucosa that lead to a condition commonly called atrophic vaginitis. Although mild genital changes occur in most women, 10–47% of postmenopausal women will develop one or more debilitating symptoms that include vulvovaginal dryness, dyspareunia, vulvar itching or pain, recurrent urinary tract infections, as well as abnormal vaginal discharge. Topical estrogen replacement therapies reverse these mucosal changes and are effective treatments for the symptoms of atrophic vaginitis. Vaginal moisturizers and lubricants also provide symptomatic relief for vaginal dryness and dyspareunia, respectively.